Eric G. Smith
University of Massachusetts Medical School
43 Papers
179 Citations
Eric G. Smith is an academic researcher from University of Massachusetts Medical School. The author has contributed to research in topics: Poison control & Medicine. The author has an hindex of 15, co-authored 41 publications. Previous affiliations of Eric G. Smith include Veterans Health Administration & Group Health Research Institute.
Chat about Author
Papers
Validation of key behaviourally based mental health diagnoses in administrative data: suicide attempt, alcohol abuse, illicit drug abuse and tobacco use
Hyungjin Myra Kim,Hyungjin Myra Kim,Eric G. Smith,Claire Stano,Dara Ganoczy,Kara Zivin,Kara Zivin,Heather Walters,Heather Walters,Marcia Valenstein,Marcia Valenstein +10 more
TL;DR: Administrative data-based diagnoses among VHA records have high specificity, but low sensitivity, and the accuracy level varies by different diagnosis and by different patient subgroup.
Reliability of a novel classification system for thoracolumbar injuries: the Thoracolumbar Injury Severity Score
Alexander R. Vaccaro,Eli M. Baron,James A. Sanfilippo,Sidney M. Jacoby,Jacob Steuve,Eric L Grossman,Matthew J. DiPaola,Paul Ranier,Luke S. Austin,Ray Ropiak,Michael Ciminello,Chuka Okafor,Matthew D. Eichenbaum,Venkat Rapuri,Eric G. Smith,Fabio Orozco,Peter Ugolini,Mark Fletcher,Jonathan Minnich,Gregory Goldberg,Jared T. Wilsey,Joon Y. Lee,Moe R. Lim,Anthony S. Burns,Ralph J. Marino,Christian P. DiPaola,Laura Zeiller,Steven C Zeiler,James S. Harrop,D. Greg Anderson,Todd J. Albert,Alan S. Hilibrand +31 more
TL;DR: The TLISS has good reliability and compares favorably to other contemporary thoracolumbar fracture classification systems.
130
Suicide Risk Assessment Received Prior to Suicide Death by Veterans Health Administration Patients with a History of Depression
Eric G. Smith,Hyungjin Myra Kim,Dara Ganoczy,Claire Stano,Paul N. Pfeiffer,Marcia Valenstein +5 more
TL;DR: Practice changes are needed to improve suicide risk assessment among patients with histories of depression, including the development of assessment and prevention strategies that are less dependent on the presence or disclosure of suicidal ideation at scheduled medical visits.
Antidepressant augmentation using the N-methyl-D-aspartate antagonist memantine: a randomized, double-blind, placebo-controlled trial.
Eric G. Smith,Kristina M. Deligiannidis,Christine M. Ulbricht,Chelsea S. Landolin,Jayendra K. Patel,Anthony J. Rothschild +5 more
TL;DR: This trial did not detect significant statistical or effect size differences between memantine and placebo augmentation among nonresponders or poor responders to conventional antidepressants, and suggests memantine lacks substantial efficacy as an augmentation treatment for major depressive disorder.
Animal models to improve our understanding and treatment of suicidal behavior
Todd D. Gould,Polymnia Georgiou,Lisa A. Brenner,Lena Brundin,Adem Can,Adem Can,P. Courtet,Zoe R. Donaldson,Yogesh Dwivedi,Sébastien Guillaume,Irving I. Gottesman,Shami Kanekar,Christopher A. Lowry,Perry F. Renshaw,Dan Rujescu,Eric G. Smith,Gustavo Turecki,Panos Zanos,Carlos A. Zarate,Patricia A. Zunszain,Teodor T. Postolache +20 more
TL;DR: Human biological findings, as well as protective effects of medications associated with modifying risk of engaging in suicidal behavior that are readily translatable to animal models, are broadly described.